drugset
drugset / Trial / NCT04089982

Varenicline Light Smoking Pilot

NCT04089982 ↗

Phase 4 Completed 11 enrolled Duke University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this study is to assess varenicline vs. placebo for its effect on decreasing cue reactivity in light and intermittent smokers.

Timeline

Start
2019-11-04
Primary completion
2020-03-01
Completion
2020-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Varenicline Small molecule — —

Indications

No indication recorded.